eSense-Cancer: Adapting an Online Intervention for Sexual Health Concerns to Gynecologic Cancer

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age19+
SponsorUniversity of British Columbia

About this trial

Sexual health is a vital component of gynecologic cancer treatment and survivorship. Unfortunately, most gynecologic cancer survivors lack sufficient information about the impact of cancer on sexual health and treatment opportunities. This research aims to assess how well an adapted online health intervention meets the sexual health needs of gynecologic cancer survivors and to test the efficacy of the new platform. If successful, eSense-Cancer may increase access to treatment for gynecologic cancer survivors, including those living in remote areas or facing other accessibility barriers. It may also fill healthcare gaps for survivors of varying ethnicity, sexual orientation, socioeconomic status, and gender.

Eligibility criteria

Qualifiers

self-report a current or history of gynecologic cancer of any subtype

self-report symptoms of sexual difficulties and score of greater than 11 on the Female Sexual Distress Scale-Revised

are fluent in English (eSense content is delivered in English)

have reliable internet access and basic competency in using online platforms (individuals will self-report)

Disqualifiers

have visual impairments or disabilities interfering with reading and ability to interact with online materials

have poorly managed anxiety or mood disorder (assessed using the degree of life interference evaluation at screening)

individuals who are in active treatment for their cancer (including radiation, chemotherapy and any planned surgeries).

Trial design

Treatments tested in this trial

  • eSense-Cancer CBT: an online cognitive-behavioural therapy based intervention for sexual health concerns after gynecologic cancer
  • Navigator support for eSense-Cancer
  • Behavioral: eSense-Cancer MBT: an online cognitive-behavioural therapy based intervention for sexual health concerns after gynecologic cancer

Treatment groups

60 Participants
are divided into 4 treatment groups

Sponsors and collaborators

University of British Columbia

Lead sponsor

Xavier University of Louisiana.

Collaborator